Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» natalizumab
natalizumab
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Xtalks
Thu, 02/8/18 - 10:11 am
Biogen
stroke
clinical trials
natalizumab